Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer

Patient Education and Counseling

Volumn 72, Issue 2, 2008, Pages 239-245

  Duric, Vlatka M ^a   Butow, Phyllis N ^a   Sharpe, Louise ^a   Heritier, Stephane ^a   Boyle, Frances ^b   Beith, Jane ^c   Wilcken, Nicholas R C ^d   Coates, Alan S ^e,f   Simes, R John ^a   Stockler, Martin R ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MATER HOSPITAL   (Australia)

^c SYDNEY CANCER CENTRE   (Australia)

^d NEPEAN HOSPITAL   (Australia)

^e Cancer Council   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adjuvant chemotherapy; Early breast cancer; Partner preferences; Patient preferences

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DECISION MAKING; FEMALE; HUMAN; INTERVIEW; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHOICE BEHAVIOR; COOPERATIVE BEHAVIOR; DISSENT AND DISPUTES; FEMALE; HUMANS; LIFE EXPECTANCY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW SOUTH WALES; PREMENOPAUSE; PROGNOSIS; QUESTIONNAIRES; SPOUSES; SURVIVAL RATE; WOMEN;

EID: 45649084854     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2008.02.021     Document Type: Article

References (24)

1. Charles C., Gafni A., and Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Social Sci Med 44 (1997) Mar-692
2. Reust C.E., and Mattingly S. Family involvement in medical decision making. Family Med 28 (1996) 39-45
3. Sutherland H.J., da Cunha R., Lockwood G.A., and Till J.E. What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials?. Med Decis Making 18 (1998) 61-69
4. National Health and Medical Research Council of Australia. Psychosocial clinical practice guidelines: information, support and counselling for women with breast cancer; 2004. Available from URL: http://nhmrc.gov.au/publications/.
5. Slevin M.L., Stubbs L., Plant H.J., Wilson P., Gregory W.M., Armes P.J., and Downer S.M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J 300 (1990) 1458-1460
6. Sneeuw K.C., Aaronson N.K., Osoba D., Muller M.J., Hsu M.A., Yung W.K., Brada M., and Newlands E.S. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 35 (1997) 490-506
7. Sneeuw K.C., Aaronson N.K., Sprangers M.A., Detmar S.B., Wever L.D., and Schornagel J.H. Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol 15 (1997) 1206-1217
8. Sneeuw K.C., Aaronson N.K., Sprangers M.A., Detmar S.B., Wever L.D., and Schornagel J.H. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol 51 (1998) 617-631
9. Sneeuw K.C., Aaronson N.K., Sprangers M.A., Detmar S.B., Wever L.D., and Schornagel J.H. Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. Br J Cancer 81 (1999) 87-94
10. Sneeuw K.C., Albertsen P.C., and Aaronson N.K. Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer. J Urol 165 (2001) 478-482
11. Srirangam S.J., Pearson E., Grose C., Brown S.C., Collins G.N., and O'Reilly P.H. Partner's influence on patient preference for treatment in early prostate cancer. BJU Int 92 (2003) 365-369
12. Duric V., and Stockler M. Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. Lancet Oncol 2 (2001) 691-697
13. Duric V.M., Stockler M.R., Heritier S., Boyle F., Beith J., Sullivan A., Wilcken N., Coates A.S., and Simes R.J. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?. Ann Oncol 16 (2005) 1786-1794
14. Shrout P.E., and Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (1979) 420-428
15. McGraw K., and Wong S. Forming inferences about some intraclass correlations coefficients: correction. Psychol Methods 1 (1996) 390
16. McGraw K., and Wong S. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1 (1996) 30-46
17. Landis J.R., and Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33 (1977) 363-374
18. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
19. Streiner D.L., and Norman G.R. Health measurement scales: a practical guide to their development and use. 3rd ed. (2003), Oxford University Press, Oxford
20. Kiebert G.M., Stiggelbout A.M., Kievit J., Leer J.W., van de Velde C.J., and de Haes H.J. Choices in oncology: factors that influence patients' treatment preference. Qual Life Res 3 (1994) 175-182
21. Llewellyn-Thomas H.A. Investigating patients' preferences for different treatment options. Can J Nurs Res 29 (1997) 45-64
22. Llewellyn-Thomas H.A., Thiel E.C., and McGreal M.J. Cancer patients' evaluations of their current health states: the influences of expectations, comparisons, actual health status, and mood. Med Decis Making 12 (1992) 115-122
23. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
24. Simes RJ, Coates AS. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? J Natl Cancer Inst 2001;Monographs:146-52.